Keywords: ACC; anterior cingulate cortex; AEDs; ntiepileptic drugs; BPRS; Brief Psychiatric Rating Scale; CBZ; carbamazepine; CZP; clonazepam; EP+DS; epilepsy patients with depressive symptoms; EP-DS; epilepsy patients without depressive symptoms; FC; functional co
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ASD; Autism Spectrum Disorders; ASQ; the Autism Screening Questionnaire; AOS; Adult onset schizophrenia; ADHD; Attention Deficit Hyperactivity Disorder; BPRS; Brief Psychiatric Rating Scale; COS; Childhood onset schizophrenia; CGAS; Children's Global Asse
Keywords: ANOVA; Analysis of Variance; BD; Bipolar Disorder; BOLD; Blood-Oxygen-Level Dependent; BPRS; Brief Psychiatric Rating Scale; DSM; Diagnostic and Statistical Manual of Mental Disorders; GM; Grey Matter; HDRS; Hamilton Depression Rating Scale; ICD; Internat
Keywords: Depression; Neurotransmitter; Pathophysiology; Systematic review; Meta-analyses; N; Number; SD; Standard deviation; P; Patients; C; Controls; M; Male; F; Female; dMDD; depressed Major Depressive Disorder; rMDD; remitted Major Depressive Disorder; NA; Not
Keywords: AGE; advanced glycation end-product; BMI; body mass index; BPRS; Brief Psychiatric Rating Scale; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders-IV; FGA; first-generation antipsychotics; GLO1; glyoxalase I; SD; standard deviation; SGA; secon
Keywords: Long acting treatment; Magnetic resonance; Clinical outcome; Schizophrenia; BPRS; Gray matter;
Keywords: Long-term assessment; Prospective study; BPRS;
Keywords: Functional MRI; Working memory; Antipsychotic medication; AAP; atypical antipsychotics; BA; Brodman area; BPRS; Brief Psychiatric Rating Scale; BOLD; blood oxygenation level dependent; CPZ-E; chlorpromazine equivalents; DOI; duration of illness; DSM; diag
Keywords: AO; assertive outreach; TAU; treatment as usual; ACT; assertive community treatment; APN; ambulant psychiatric nurse; SMI; severely mentally ill; GAF; Global Assessment of Functioning Scale; BPRS; Brief Psychiatric Rating Scale; CSSRI; Client Social Servi
Keywords: BPRS; Brief Psychiatric Rating Scale; CGI-S; Clinical Global Impression-Severity of Illness; CP; chlorpromazine-equivalent doses of antipsychotics; DRD2; dopamine D2 receptors; DSP; dopamine supersensitivity psychosis; GAF; Global Assessment of Functionin
Keywords: First episode schizophrenia; Negative symptoms; Neuropsychological tests; SANS; SAPS; BPRS
Keywords: BPRS; Brief Psychiatric Rating Scale; CASH; Comprehensive Assessment of Symptoms and History; CDSS; Calgary Depression Scale for Schizophrenia; CI; Confidence interval; CPT; Continuous Performance Test; DAS; Disability Assessment Scale; DSM; Diagnostic an
Keywords: BDI; Beck depression inventory scale; BPRS; brief psychiatric rating scale; CT; computed tomography; DSM-IV-TRd; iagnostic and statistical manual of mental disorders, fourth edition, text revision; GAF; global assessment of functioning; GCS; Glasgow coma
Keywords: Early psychosis; Assessment; Symptoms; BPRS; SANS/SAPS; PANSS; SOPS;
Keywords: AHS; Auditory Hallucinations Scale; ANOVA; analysis of variance; AVH; auditory verbal hallucinations; BPRS; Brief Psychiatric Rating Scale; COI; component of interest; DARTEL; diffeomorphic anatomic registration through exponentiated lie algebra; DSM-IV;
Keywords: BPRS; brief psychiatric rating scale; DS; deficit schizophrenia; HC; healthy control; NDS; nondeficit schizophrenia; OSI; oxidative stress index; SANS; scale for the assessment of negative symptoms; SAPS; scale for the assessment of positive symptoms; SCI
Keywords: MDA; malondialdehyde; 4-HNE; 4-hydroxynonenal; ARA; arachidonic acid; EPA; eicosapentaenoic acid; DHA; docosahexaenoic acid; BPRS; Brief Psychiatric Rating Scale; PANSS; Positive and Negative Symptom Scale; PUFAs; polyunsaturated fatty acids; ROS; reactiv
Keywords: MMN; mismatch negativity; ERP; event-related potential; EEG; electroencephalography; EOG; electro-oculogram; HDRS; Hamilton depressive rating scale; BPRS; brief psychiatric rating scale; SOFAS; social and occupational functioning scale; TMT; trails making
Keywords: PUFAs; Polyunsaturated fatty acids; ROS; Reactive oxygen species; RNS; Reactive nitrogen species; NO; Nitrous oxide; NOÂ +; Nitrosonium cation (NOÂ +); NOâ; Nitroxyl anion; ONOOâ; Peroxynitrite; SOD; Superoxide dismutase; CAT; Catalase; GPx; Glutathio
DNA methylation and gene expression of the chemokine (C-X-C motif) ligand 1 in patients with deficit and non-deficit schizophrenia
Keywords: CXCL1; Deficit Schizophrenia (DS); DNA methylation; Gene expression; NDS; non-deficit schizophrenia; CXCL1; chemokine (C-X-C motif) ligand 1; PMBCs; peripheral blood mononuclear cells; CpG; C-phosphate-G; DSM-IV; Diagnostic and Statistical Manual of Menta
Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia
Keywords: AGE; advanced glycation end product; Glycer-AGE; glyceraldehyde-derived AGE; RAGE; AGE receptors; sRAGE; soluble AGE receptors; esRAGE; endogenous secretory RAGE; ANCOVA; analysis of covariance; BMI; body mass index; BPRS; brief psychiatric rating scale;
Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8Â years later
Keywords: Schizophrenia; Negative symptoms; Long-term follow-up; Functional outcome; Symptom exacerbation; Intraclass correlation coefficient; BPRS; SANS;
Impact of BPRS interview length on ratings reliability in a schizophrenia trial
Keywords: Clinical trials; BPRS; Interview length; Schizophrenia; Ratings precision; Inter-rater reliability;
Equipercentile linking of the BPRS and the PANSS
Keywords: PANSS; BPRS; Equipercentile linking
The Brief Psychiatric Rating Scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression
Keywords: BPRS; Depression; Crisis Intervention Centre
Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation
Keywords: VBM; voxel-based morphometry; DARTEL; Diffeomorphic Anatomical Registration Through Exponentiated Lie algebra; SVC; small volume correction; ROI; region of interest; FDR; false discovery rate; FESZ; first-episode schizophrenia; HC; healthy control subject
Recommendations for the diagnosis and management of Niemann-Pick disease type C: An update
Keywords: ACE; Addenbrooke's Cognitive Examination; ASM; acid sphingomyelinase; ALAT; alanine aminotransferase; ASAT; aspartate aminotransferase; BARS; Brief Ataxia Rating Scale; BPRS; Brief Psychiatric Rating Scale; BSID; Bayley Scales for Infant Development; cDNA
Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS)
Keywords: BPRS; Brief Psychiatric Rating Scale; CP; chlorpromazine; CGI-S; Clinical Global Impressions-Severity scale; CGI-I; Clinical Global Impressions-Improvement scale; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders-IV; DISC1; Disrupted-in-Schizo
Aggression and psychopharmacological treatments in major psychosis and personality disorders during hospitalisation
Keywords: BPRS; Brief Psychiatric Rating Scales; FDA; Food and Drug Administration; DSM-IV-TR; Diagnostic and Statistical Manual of Mental Disorders,4th edition Text Revision; GABA; gamma-amnobutyric acid; MOAS; Modified Overt Aggression Scale; SCID I; Structured C
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: Preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects
Keywords: CBD; cannabidiol; THC; tetrahydrocannabinol; CB1; cannabinoid-1; CB2; cannabinoid-2; NMDA; N-methyl-d-aspartate; PPI; prepulse inhibition; SCID-NP; structured clinical interview for the DSM-non-patient edition; SPSS; Severity of Psychosocial Stressors Sca
Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia
Keywords: BDNF; Brain-derived neurotrophic factor; BMI; Body-mass index; BPRS; Brief psychiatry rating scale; DIEPSS; Drug induced extrapyramidal symptoms scale; DSDT; Digit span distraction test; ELISA; Enzyme-linked immunosorbent assay; IQ; Intelligence quotient;
Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients
Keywords: ANOVA; analysis of variance; BPRS; Brief Psychiatric Rating Scale; CAT; catalase; ECT; electroconvulsive therapy; ECS; electroconvulsive shock; GSH; glutathione; GSH-Px; glutathione peroxidase; MDA; malondialdehyde; NO; nitric oxide; ROS; reactive oxygen
The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients
Keywords: GSK3β; Glycogen Synthase Kinase 3-beta; YMRS; Young Mania Rating Scale; BPRS; Brief Psychiatric Rating Scale; SNP; Single Nucleotide Polymorphism; DSM-IV; diagnosis criteria of Diagnostic and Statistical Manual of Mental Disorders-IV; SCID-I; Structured
An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia
Keywords: BPRS; Brief Psychiatric Rating Scale; CA; Categories Achieved; DMS; Difficulty Maintaining Set; DVR; Delayed Verbal Recall; DVRG; Delayed Verbal Recognition; IVR; Immediate Verbal Recall; KWCST; Wisconsin Card Sorting Test Keio Version; MFT; Memory Filter
Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance
Keywords: BD; bipolar disorder; SCZ; schizophrenia; PUFA; polyunsaturated fatty acid; DSM; diagnostic and statistical manual; BPRS; brief psychiatric rating scale; PANSS; positive and negative symptom scale; CGI; clinical global impression; HDRS; Hamilton depressio
Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophrenia
Keywords: BPRS; Brief Psychiatry Rating Scale; CSF; cerebrospinal fluid; DAO; d-amino acid-oxidase; GLS1 and GLS2; glutaminase 1 and 2; MRS; magnetic resonance spectroscopy; mGluRs; metabotropic glutamate receptors; NMDA; N-methyl d-aspartate; PCP; phencyclidine; P
Impact of panic attacks on quality of life among patients with schizophrenia
Keywords: BPRS; Brief Psychiatric Rating Scale; CDS; Calgary Depression Scale; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition; PA; panic attack; PANSS; Positive and Negative Syndrome Scale; PD; panic disorder; QOL; quality of life; SCI
The model of the relationships among the predictors of quality of life in chronic stage of schizophrenia
Keywords: AGFI; adjusted goodness of fit index; BPRS; Brief Psychiatric Rating Scale; CFI; comparative fit index; EXIT; Executive Interview; LUNSERS; Liverpool University Neuroleptic Side Effects Rating Scale; QLS; Heinrichs Quality of Life Scale; QoL; quality of l
Validity of the BPRS, the BDI and the BAI in dual diagnosis patients
Keywords: Psychopathology; Schizophrenia; Dual diagnosis; Diagnostic validity; Inpatient; BPRS; BDI; Depression; Substance abuse
Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia
Keywords: AH; auditory hallucinations; 1H MRS; Proton Magnetic Resonance Spectroscopy; MRI; Magnetic Resonance Imaging; MRSI; Magnetic Resonance Spectroscopy Imaging; NAA; N-acetylaspartate; Cho; Choline; Cr; Creatine; BPRS; Brief Psychiatric Rating Scale; PANSS; P
Characteristics and clinical correlates of restless legs syndrome in schizophrenia
Keywords: AIS; Athens Insomnia Scale; AIS-8; Athens Insomnia Score-8; BARS; Barnes Akathisia Rating Scale; BPRS; Brief Psychiatric Rating Scale; df; degrees of freedom; IRLS; International Restless Legs Syndrome Study Group rating scale; IRLSSG; International Restl
Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: A randomized, open-label, controlled trial
Keywords: AIMS; Abnormal Involuntary Movement Scale; BAS; Barnes Akathisia Scale; BDI; Beck Depression Inventory; BPRS; Brief Psychiatric Rating Scale; CDSS; Calgary Depression Scale for Schizophrenia; EPS; extrapyramidal symptoms; GAF; Global Assessment of Functio
Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: Effects of short term antipsychotic treatment
Keywords: BPRS; Brief Psychiatric Rating Scale; GPx; Glutathione peroxidase; MDA; Malondialdehyde; PANSS; Positive and the negative syndrome scale; RBC; Red blood cells; SANS; Scale for Assessment of Negative Symptoms; SAPS; Scale for Assessment of Positive Symptom
Quetiapine in combination with citalopram in patients with unipolar psychotic depression
Keywords: AE; adverse events; BPRS; Brief Psychiatric Rating Scale; CGI; Clinical Global Impression; DSM-IV; Statistical Manual of Mental Disorders, 4th edition; HAM-D-21; Hamilton Rating Scale for Depression; ICD; International Statistical Classification of Diseas
Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia
Keywords: Clozapine response; Predictor; Treatment-resistant schizophrenia; BPRS; Brief Psychiatric Rating Scale; NICE; National Institute of Clinical Excellence; SANS; Scale for the Assessment of Negative Symptoms; SAPS; Scale for the Assessment for Positive Sympt
The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients
Keywords: BPRS; the Brief Psychotic Rating Scale; D2; dopamine type 2; PRL; prolactin; Clinical efficacy; Prolactin; Risperidone; Schizoaffective disorder; Schizophrenia;
Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: An open trial
Keywords: BPRS; brief psychiatric rating scale; CGI; clinical global impression; ESRS; extra-pyramidal symptom rating scale.; First-episode schizophrenia; Olanzapine; Open trial; Risperidone; Switching;
Dopamine D2 receptor occupancy by risperidone: Implications for the timing and magnitude of clinical response
Keywords: Brief Psychiatric Rating Scale; BPRS; Dopaminergic D2 receptors; D2R; Extrapyramidal Side Effects; EPS; 123I-Iodobenzamide; IBZM; Positive and Negative Syndrome Scale; PANSS; Positron Emission Tomography; PET; Region of Interest for Striatum; ROIs; Single
Troubles anxio-dépressifs et qualité de l'hémodialyse
Keywords: Dépression; Anxiété; Hémodialyse adéquate; Qualité de dialyse; Troubles psychiatriques; Depression; Anxiety; Adequate haemodialysis; Quality in haemodialysis; Psychiatric disorders; BPRS; Brief Pyschiatric Rating Scale (échelle abrégée d'appréci
Safety and effectiveness of olanzapine in monotherapy: A multivariate analysis of a naturalistic study
Keywords: BPRS; Brief Psychiatric Rating Scale; CA; conventional antipsychotics; CG; group of patients treated with conventional antipsychotics; CGI-S; Clinical Global Impression of Severity; EPS; extrapyramidal symptoms; ICD-10; International Classification of Dis